AI Analysis AI Analysis of AMPH AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add AMPH to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Friday for Amphastar Pharmaceuticals
(Updated on Jul 31, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 21, 2026 Gain 1.79%

The Amphastar Pharmaceuticals stock price fell by -2.16% on the last day (Friday, 31st Jul 2026) from $20.38 to $19.94. During the last trading day the stock fluctuated 3.66% from a day low at $19.67 to a day high of $20.39. The price has fallen in 7 of the last 10 days but is still up by 0.99% over the past 2 weeks. Volume has increased on the last day by 8 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 359 thousand shares were bought and sold for approximately $7.16 million.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Amphastar Pharmaceuticals stock with a 90% probability to be traded between $17.03 and $21.92 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

AMPH Signals & Forecast

The Amphastar Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $19.69 and $19.73. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, June 26, 2026, and so far it has fallen -8.45%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Amphastar Pharmaceuticals stock

Amphastar Pharmaceuticals finds support from accumulated volume at $19.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.720 between high and low, or 3.66%. For the last week, the stock has had daily average volatility of 3.31%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AMPH) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Amphastar Pharmaceuticals to open at $20.00, and during the day (based on 14 day Average True Range), to move between $19.55 and $20.33, which gives a possible trading interval of +/-$0.772 (+/-3.95%) up or down from last closing price. If Amphastar Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 3.95% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $19.96 (0.10%) than the support at $19.00 (4.71%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

Amphastar Pharmaceuticals will release earnings AMC on Thursday, August 06, 2026.The consensus among the analysts for the expected earnings (EPS) is $0.660. We will update the financials statements for Amphastar Pharmaceuticals, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 3.92% in the first trading day after earnings release.

Is Amphastar Pharmaceuticals stock A Buy?

Amphastar Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.592 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $20.00 ( 0.284%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

AMPH Performance

Trading levels for AMPH

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 20.72 3.90%
R2 20.44 2.52%
R1 20.27 1.66%
Price 19.94
S1 19.72 -1.10%
S2 19.55 -1.95%
S3 19.28 -3.33%

Accumulated Volume Support & Resistance Levels

Level Price
R3 21.02 5.42%
R2 20.71 3.86%
R1 19.96 0.100%
Price 19.94
S1 19.00 -4.71%
S2 18.81 -5.67%
S3 18.16 -8.93%

AMPH Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jun 07, 2010 Jun 11, 2010 Jun 30, 2010 $0.300 0%
2 Jun 05, 2009 Jun 11, 2009 Jun 30, 2009 $0.300 0%

FAQ

What is the symbol for Amphastar Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Amphastar Pharmaceuticals is AMPH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Amphastar Pharmaceuticals Stock?
Amphastar Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Amphastar Pharmaceuticals Stock?
Amphastar Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Amphastar Pharmaceuticals Stock.

What's the current price of Amphastar Pharmaceuticals Stock?
As of the end of day on the Jul 31, 2026, the price of an Amphastar Pharmaceuticals (AMPH) share was $19.94.

What is the 52-week high and low for Amphastar Pharmaceuticals Stock?
The 52-week high for Amphastar Pharmaceuticals Stock is $31.26 and the 52-week low is $16.65.

What is the market capitalization of Amphastar Pharmaceuticals Stock?
As of the Jul 31, 2026, the market capitalization of Amphastar Pharmaceuticals is 879.213M.

When is the next earnings date for Amphastar Pharmaceuticals?
The upcoming earnings date for Amphastar Pharmaceuticals is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT AMPHASTAR PHARMACEUTICALS
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Eno...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE